5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.06▼ | 7.96▲ | 7.95▲ | 8.30▼ | 8.44▼ |
MA10 | 8.03▼ | 7.94▲ | 7.93▲ | 8.32▼ | 9.03▼ |
MA20 | 7.97▲ | 7.95▲ | 8.05▼ | 9.09▼ | 9.66▼ |
MA50 | 7.93▲ | 8.28▼ | 8.39▼ | 9.02▼ | 11.38▼ |
MA100 | 7.98▲ | 8.38▼ | 8.59▼ | 9.93▼ | N/A |
MA200 | 8.34▼ | 8.70▼ | 9.46▼ | 11.27▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.009▲ | 0.034▲ | 0.016▲ | -0.116▼ | -0.028▼ |
RSI | 55.777▲ | 48.406▼ | 42.391▼ | 43.150▼ | 42.164▼ |
STOCH | 81.590▲ | 66.235 | 47.479 | 31.829 | 41.049 |
WILL %R | -40.000 | -26.667 | -53.684 | -84.299▼ | -69.572 |
CCI | 46.571 | 158.020▲ | 101.832▲ | -84.896 | -76.796 |
CDL | $GYRE Doji Candlestick Pattern Detected | Set Alert |
Tuesday, June 10, 2025 04:00 AM
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first ...
|
Thursday, May 29, 2025 08:48 PM
Gyre Therapeutics, Inc. (NASDAQ:GYRE), a biopharmaceutical company developing innovative fibrosis-focused therapies, has successfully closed a public offering, raising approximately $23 million in ...
|
Thursday, May 29, 2025 08:34 PM
Gyre Therapeutics, Inc. (NASDAQ:GYRE), a biopharmaceutical company developing innovative fibrosis-focused therapies, has successfully closed a public offering, raising approximately $23 million in ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 8.07 | 8.29 | 7.76 | 8.03 | 165,400 |
13/06/25 | 7.99 | 8.3857 | 7.88 | 7.99 | 143,723 |
12/06/25 | 8.41 | 8.56 | 8.05 | 8.07 | 183,581 |
11/06/25 | 9.00 | 9.19 | 8.44 | 8.44 | 186,316 |
10/06/25 | 8.75 | 9.05 | 8.72 | 8.98 | 232,945 |
09/06/25 | 8.55 | 8.81 | 8.4425 | 8.50 | 198,141 |
06/06/25 | 8.04 | 8.50 | 8.01 | 8.41 | 158,300 |
05/06/25 | 8.60 | 8.7721 | 7.92 | 7.97 | 271,707 |
04/06/25 | 8.20 | 8.61 | 8.13 | 8.58 | 192,310 |
03/06/25 | 7.87 | 8.58 | 7.80 | 8.22 | 362,600 |
|
|
||||
|
|
||||
|
|